Skip to main content
. 2013 Dec 15;7(1):110–122.

Figure 2.

Figure 2

Foxl1 protein expression in renal cancer and patient survival. A: Immunohistochemical analysis of Foxl1 protein expression in 88 patients of ccRCC tissues. a: Immunohistochemistry expression of Foxl1 in adjacent non-tumor tissue (× 200). b: Immunohistochemistry expression of Foxl1 in adjacent non-tumor tissue (× 400). c: Immunohistochemistry expression of Foxl1 in tumor tissue (× 200). d: Immunohistochemistry expression of Foxl1 in tumor tissue (× 400). B: The survival analysis of Foxl1. Patients with lower Foxl1 expression in tumor tissue were closely correlated with poorer overall survival than patients with tumor with higher Foxl1 expression (p<0.05, respectively).